ARCHIVES

Talking Back: FDA Faces Challenges Over Avastin & Prostate Cancer Prevention

This article is from The Cancer Letter archive.

Vol. 37 No. 03 | January 21, 2011

Download PDF Visit The Full Archive

Related Articles

“We Will Move Forward With Bold Expectations,” NCI Director Says

October 2, 1998

NIH Changes SBIR/STTG Application Receipt Dates.

February 18, 2000

Wilmot Researchers Study Combination for Lymphoma

September 26, 2003

Nomograms 66% Correct In Predicting Outcome For Brachytherapy, Study Finds

September 28, 2001

In Brief: Bruce Chamber Is DeVita’s Choice as Permanent Director Of DCT; Six New RCDAs Funded In FY 1982

June 11, 1982

AOR And PRN, Two Largest Oncology Practice Management Firms, To Merge

December 18, 1998